S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

Home
Investing
Stocks
UK
LSE
Crism Therapeutics Corporation (CRTX)
Crism Therapeutics Corporation (CRTX) News

CRTX

Crism Therapeutics (CRTX)

Crism Therapeutics Corporation

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:CRTX

1

Date	Time	Source	Headline	Symbol	Company
04/06/2024	00:25	RNS Regulatory News	Crism Therapeutics Corporation Director Dealing	LSE:CRTX	Crism Therapeutics Corporation
01/06/2024	06:58	Alliance News	IN BRIEF: Crism has first day of trade on AIM after name change, buy	LSE:CRTX	Crism Therapeutics Corporation
31/05/2024	16:00	RNS Regulatory News	Crism Therapeutics Corporation Admission to Trading and First Day of Dealings	LSE:CRTX	Crism Therapeutics Corporation
19/12/2009	05:45	PR Newswire (US)	Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010	NASDAQ:CRTX
21/11/2009	07:40	PR Newswire (US)	Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal	NASDAQ:CRTX
17/11/2009	00:00	PR Newswire (US)	Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference	NASDAQ:CRTX
14/11/2009	00:00	PR Newswire (US)	Cornerstone Therapeutics Appoints General Counsel	NASDAQ:CRTX
04/11/2009	23:00	PR Newswire (US)	Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results	NASDAQ:CRTX
21/10/2009	23:00	PR Newswire (US)	Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call	NASDAQ:CRTX
03/09/2009	22:01	PR Newswire (US)	Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)	NASDAQ:CRTX
03/09/2009	22:00	PR Newswire (US)	Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:CRTX
20/07/2009	22:00	PR Newswire (US)	Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal	NASDAQ:CRTX
16/07/2009	09:04	PR Newswire (US)	Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product	NASDAQ:CRTX
09/07/2009	06:15	PR Newswire (US)	Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect t	NASDAQ:CRTX
13/06/2009	06:35	Dow Jones News	UPDATE:FDA Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
13/06/2009	05:28	Dow Jones News	FDA: Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
20/05/2009	06:01	PR Newswire (US)	Cornerstone Therapeutics Announces Management Change	NASDAQ:CRTX
07/05/2009	21:01	PR Newswire (US)	Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA	NASDAQ:CRTX
07/05/2009	21:00	PR Newswire (US)	Cornerstone Therapeutics Reports First Quarter 2009 Financial Results	NASDAQ:CRTX
27/04/2009	22:00	PR Newswire (US)	Cornerstone Therapeutics to Host First Quarter 2009 Conference Call	NASDAQ:CRTX
14/01/2009	09:33	Dow Jones News	UPDATE: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
14/01/2009	07:34	Dow Jones News	FDA: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
06/11/2008	00:00	PR Newswire (US)	Cornerstone Therapeutics Announces New Board of Directors	NASDAQ:CRTX
02/08/2006	00:00	PR Newswire (US)	Critical Therapeutics Files Controlled Release Formulation of Zileuton	NASDAQ:CRTX

Showing the most relevant articles for your search:LSE:CRTX

1

Societe Generale Effekten

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions